Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2002 1
2004 1
2005 2
2006 2
2007 2
2008 5
2009 2
2010 3
2011 3
2012 1
2013 3
2014 7
2015 4
2016 3
2017 2
2018 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Developmental pathways activated in melanocytes and melanoma.
Liu J, Fukunaga-Kalabis M, Li L, Herlyn M. Liu J, et al. Arch Biochem Biophys. 2014 Dec 1;563:13-21. doi: 10.1016/j.abb.2014.07.023. Epub 2014 Aug 8. Arch Biochem Biophys. 2014. PMID: 25109840 Free PMC article. Review.
Narrowing the knowledge gaps for melanoma.
Slipicevic A, Herlyn M. Slipicevic A, et al. Ups J Med Sci. 2012 May;117(2):237-43. doi: 10.3109/03009734.2012.658977. Epub 2012 Feb 16. Ups J Med Sci. 2012. PMID: 22339359 Free PMC article. Review.
MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression.
Heppt MV, Wang JX, Hristova DM, Wei Z, Li L, Evans B, Beqiri M, Zaman S, Zhang J, Irmler M, Berking C, Besch R, Beckers J, Rauscher FJ 3rd, Sturm RA, Fisher DE, Herlyn M, Fukunaga-Kalabis M. Heppt MV, et al. J Invest Dermatol. 2018 Jan;138(1):141-149. doi: 10.1016/j.jid.2017.05.038. Epub 2017 Sep 18. J Invest Dermatol. 2018. PMID: 28927893 Free PMC article.
PIM kinases as therapeutic targets against advanced melanoma.
Shannan B, Watters A, Chen Q, Mollin S, Dörr M, Meggers E, Xu X, Gimotty PA, Perego M, Li L, Benci J, Krepler C, Brafford P, Zhang J, Wei Z, Zhang G, Liu Q, Yin X, Nathanson KL, Herlyn M, Vultur A. Shannan B, et al. Oncotarget. 2016 Aug 23;7(34):54897-54912. doi: 10.18632/oncotarget.10703. Oncotarget. 2016. PMID: 27448973 Free PMC article.
A slow-cycling subpopulation of melanoma cells with highly invasive properties.
Perego M, Maurer M, Wang JX, Shaffer S, Müller AC, Parapatics K, Li L, Hristova D, Shin S, Keeney F, Liu S, Xu X, Raj A, Jensen JK, Bennett KL, Wagner SN, Somasundaram R, Herlyn M. Perego M, et al. Oncogene. 2018 Jan 18;37(3):302-312. doi: 10.1038/onc.2017.341. Epub 2017 Sep 18. Oncogene. 2018. PMID: 28925403 Free PMC article.
CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
McNeal AS, Liu K, Nakhate V, Natale CA, Duperret EK, Capell BC, Dentchev T, Berger SL, Herlyn M, Seykora JT, Ridky TW. McNeal AS, et al. Cancer Discov. 2015 Oct;5(10):1072-85. doi: 10.1158/2159-8290.CD-15-0196. Epub 2015 Jul 16. Cancer Discov. 2015. PMID: 26183406 Free PMC article.
41 results